| Literature DB >> 30405912 |
Abstract
AIM: To determine the prevalence and frequency of different pathological patterns of glomerulonephritis (GN) in adolescent (age ≥ 11 years) and adult Jordanian patients.Entities:
Year: 2018 PMID: 30405912 PMCID: PMC6201331 DOI: 10.1155/2018/2751372
Source DB: PubMed Journal: Int J Nephrol
Distribution of glomerular diseases based on incidence and patients' sex.
|
|
|
|
|
|
|---|---|---|---|---|
|
| ||||
|
| ||||
| MGN | 32 (15.3%) | 20 (22.7%) | 12 (9.9%) | 0.018 |
| IgAN | 17 (8.1%) | 9 (10.2%) | 8 (6.6%) | 0.244 |
| FSGS | 12 (5.7%) | 8 (9.1%) | 4 (3.3%) | 0.071 |
| MCD | 10 (4.8%) | 6 (6.8%) | 4 (3.3%) | 0.198 |
| MesPGN | 9 (4.3%) | 5 (5.7%) | 4 (3.3%) | 0.309 |
| MPGN | 9 (4.3%) | 2 (2.3%) | 7 (5.8%) | 0.189 |
| Chronic GN | 9 (4.3%) | 7 (8.0%) | 2 (1.7%) | 0.189 |
| Post infectious GN | 4 (1.9%) | 3 (3.4%) | 1 (0.8%) | 0.202 |
| Alport disease | 1 (0.5%) | 1 (1.1%) | 0 | 0 |
| CGN | 4 (1.9%) | 2 (2.3%) | 2 (1.7%) | 1 |
|
| ||||
|
| ||||
|
| ||||
| Lupus nephritis | 70 (33.5%) | 10 (11.4%) | 60 (49.6%) | < .001 |
| Diabetic nephropathy | 23 (11.0%) | 11 (12.5%) | 12 (9.9%) | 0.355 |
| Fibrillary | 5 (2.4%) | 2 (2.3%) | 3 (2.5%) | 0.647 |
| Renal amyloidosis | 4 (1.9%) | 3 (3.4%) | 1 (0.8%) | 0.202 |
|
| ||||
|
| 209 (100%) | 88 (42.1%) | 121 (57.9%) | |
Statistically significant difference. FSGS: focal and segmental glomerulosclerosis; MGN: membranous glomerulonephritis; IgAN: IgA nephropathy; MPGN: membranoproliferative glomerulonephritis; CGN: crescentic glomerulonephritis; MCD: minimal change disease; MesPGN: mesangioproliferative glomerulonephritis; GN: glomerulonephritis.
Figure 1Incidence of different histopathological patterns of glomerulonephritis in the study population.
Distribution of glomerular diseases based on etiology.
|
|
|
|
|
|---|---|---|---|
|
| 45 (42.1%) | 76 (74.5%) | < .001 |
|
| 62 (57.9%) | 26 (25.5%) | |
|
| |||
|
| 107 (51.2%) | 102 (48.8%) | |
Statistically significant difference.
Distribution of glomerular diseases based on patients' age.
| Diagnosis | Adolescent | Adult | Elderly |
|---|---|---|---|
| Primary Glomerulonephritis | |||
|
| |||
| MGN | 2 (8.7%) | 27 (15.8%) | 3 (20.0%) |
| IgAN | 1 (4.3%) | 16 (9.4%) | 0 (0%) |
| FSGS | 3 (13.0%) | 9 (5.3%) | 0 (0%) |
| MCD | 4 (17.4%) | 6 (3.5%) | 0 (0%) |
| MesPGN | 2 (8.7%) | 7 (4.1%) | 0 (0%) |
| MPGN | 1 (4.3%) | 8 (4.7%) | 0 (0%) |
| Chronic GN | 0 (0%) | 8 (4.7%) | 1 (6.7%) |
| Post infectious GN | 0 (0%) | 4 (2.3%) | 0 (0%) |
| Alport disease | 0 (0%) | 1 (0.58%0 | 0 (0%) |
| CGN | 0 (0%) | 4 (2.3%) | 0 (0%) |
|
| |||
| Secondary Glomerulonephritis | |||
|
| |||
| Lupus nephritis | 10 (43%) | 58 (33.9%) | 2 (13.3%) |
| Diabetic nephropathy | 0 (0%) | 17 (9.9%) | 6 (40%) |
| Fibrillary | 0 (0%) | 4 (2.3%) | 1 (6.7%) |
| Renal amyloidosis | 0 (0%) | 2 (1.2%) | 2 (13.3%) |
|
| |||
| Total | 23 (11.0%) | 171 (81.8%) | 15 (7.2%) |
Figure 2Different histopathological patterns of glomerulonephritis within the subgroup of primary and secondary GN.